New immune system understanding may help doctors target cancer
CU study shows new way that natural killer target cancer
read more
$4M grant aims to reduce stress in cancer caregivers
The grant leverages the expertise of co-principal investigators Cathy Bradley, PhD, a health economist, and Mark Laudenslager, PhD, a stress researcher.
read more
Biotech fieldtrip helps CU Research Summer Fellowship Program students explore range of career options
Students visited the Biosciences 2 building to see biotech in action
read more
Denver Over the Edge: Rappel a skyscraper to raise money for cancer research!
Now's your chance to rappel (or peer-pressure a friend to rappel) 34 stories!
read more
$1.6M grant will help CU Cancer Center Summer Research Fellowship Program increase diversity and innovation
NCI grant will help modernize CU's long-running program.
read more
A Deeper Look in to Early-Onset Colorectal Cancer
CU Cancer Center doctors and researchers were part of a first-of-its-kind paper focused on Young Colorectal Cancer
read more
Support Colorado Cancer Research at Race 4 Research!
Join CU Cancer Center on August 18th for the Race 4 Research 5K!
read more
National Cancer Institute grant helps speed process of Colorado clinical trials
NCI grant makes more trials available sooner to patients who need them
read more
Combined breast and gynecologic surgery: Study says not so fast
Patients undergoing coordinated breast and gynecologic procedures had significantly higher complication rates
read more
Dinner in White returns to Denver 8-10-19!
The University of Colorado Cancer Center is thrilled to announce that Dinner in White will return to Denver on August 10, 2019! The event, which is held at a secret location, raises awareness of the life-saving research, clinical trials, and cutting-edge treatments at...
Endometrial cancer clinical trial aims to pave the way for practice-changing therapy
The University of Colorado Cancer Center is leading the way in the development of a new endometrial cancer clinical trial that may lead to practice-changing therapies in the future.
read more
Knowing BRCA status associated with better breast cancer outcomes for women who decide against preventive surgery
Even in women who choose against preventive surgery, knowing BRCA status boosts survival by 24 percent
read more
Jean Mulcahy-Levy, MD, earns R01 grant to improve pediatric brain cancer treatment
Clinical trial hopes to expand use of anti-autophagy drugs in brain cancer
read more
Ben Walburn: All the Time in the World
By the time you read this, Ben Walburn will almost certainly have passed. Now, in early May, I don’t know if he will use a prescription to end his life. I also don’t know that it matters.
read more
With help from CU Cancer Center Adrenal Cancer Multidisciplinary Team, Grace Krenrich is racing ahead with life
"I trust them with my life, I feel like they saved my life,” Grace says.
read more
Saketh Guntupalli on leadership vision, higher survival rates for gynecologic cancers
“Care requires a balance between being aggressive to treat their cancer while also looking at them as a person,” says Saketh Guntupalli, MD.
read more
Immune system damage may explain ineffectiveness of high-dose radiation against lung cancer
14.3 month vs. 28.2 month median survival for high- vs. low-dose radiation.
read more
CU Cancer Center Deputy Director, Cathy J. Bradley, PhD, earns grant to close urban-rural cancer care gap
$2 million grant from the National Cancer Institute will help find actionable steps to shrink the gap between rural and urban cancer care.
read more
How human genetic data could help dogs fight cancer
“We’re taking what we know from human cancers to help move canine cancer treatment forward faster,” says Dawn L. Duval,
read more
CU Cancer Center Neuroendocrine Tumor Multidisciplinary Clinic
CU Cancer Center brings together more than 20 experts to offer multi-disciplinary care for patients with neuroendocrine masses.
read more
Immunotherapy and HDAC inhibition are anti-cancer besties
CU study shows that adding HDAC inhibitor sensitized cancers to anti-PD1 therapy.
read more
God doesn’t play dice. Does cancer?
"These mutations are disadvantageous in youth, but become advantageous later in life,” says James DeGregori, PhD.
read more
A New Normal: Kreg’s Story
"When I was diagnosed with cancer for the second time I thought ‘Okay my time is limited, how can I make the most of it this?’ I decided to grow from this experience."
read more
Three-drug cocktail of targeted therapies promising against hormone receptor and HER2 positive metastatic breast cancer
Tucatinib, palbociclib and letrozole: Overall well-tolerated with promising anti-cancer activity.
read more
OnKure and CU Cancer Center announce first patient enrolled in clinical trial of OKI-179, a potent and selective HDAC inhibitor
"We successfully dosed the first patient and the patient is doing well,” says Jennifer Diamond, MD.
read more
New Investigator Award helps Tyler Robin, MD, PhD bring new clinical trials to Colorado
“This award will help to bring new clinical trials to Colorado patients who could benefit."
read more
“Miracle drug” helps patient with recurring prostate cancer find his inner-poet
Clinical trial gives patient with recurring prostate cancer more time.
read more
From hours to live to thriving: Johnna’s story
Johnna was near death when she arrived at the CU Cancer Center. Now she is living the life she always wanted.
read more
ASCO: Finally, a tool to predict response to chemotherapy before bladder cancer surgery
“The idea is that for any individual tumor, its gene expression could tell us whether the cancer will respond to a certain kind of chemotherapy,” says Thomas Flaig, MD.
read more
ASCO: Sexual health interventions after treatment are an unmet need for gynecologic cancer patients
"We have the opportunity to meet an unmet need with our patients," says Lindsay Welton, MD candidate, first author on the study.
read more